Carboxymethyl high amylose starch: Chitosan self-stabilized matrix for probiotic colon delivery

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 70, Issue 2, 2008, Pages 582-589

  Calinescu, Carmen ^a   Mateescu, Mircea Alexandru ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Carboxymethyl high amylose starch; Chitosan; Colon delivery; Lactobacillus rhamnosus probiotic; Tablet

Indexed keywords

AMYLOSE; CARBOXYMETHYL HIGH AMYLOSE STARCH; CHITOSAN; EXCIPIENT; PROBIOTIC AGENT; STARCH; UNCLASSIFIED DRUG;

ACIDITY; ARTICLE; COLON; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; HYDROPHILICITY; LACTOBACILLUS RHAMNOSUS; MOLECULAR WEIGHT; PROTON TRANSPORT; SIMULATION; STOMACH PROTECTION; TABLET COMPRESSION; TABLET FORMULATION;

AMYLOSE; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; COLON; DRUG DELIVERY SYSTEMS; MOLECULAR WEIGHT; PROBIOTICS; SOLUBILITY; STARCH;

EID: 52949137057     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.06.006     Document Type: Article

References (28)

1. Schiffrin E.J., Brassart D., Servin A.L., Rochat F., and Donnet-Hughes A. Immune modulation of blood leukocytes in humans by lactic acid bacteria: criteria for strain selection. Am. J. Clin. Nutr. 66 (1997) 515S-520S
2. Parra M.D., Martinez de Morentin B.E., Cobo J.M., Mateos A., and Martinez J.A. Daily ingestion of fermented milk containing Lactobacillus casei DN114001 improves innate-defense capacity in healthy middle-aged people. J. Physiol. Biochem. 60 (2004) 85-91
3. Elliot S.N., Buret A., McKnight W., Miller M.J., and Wallace J.L. Bacteria rapidly colonize and modulate healing of gastric ulcers in rats. Am. J. Physiol. 275 (1998) G425-G432
4. Bennet R.G., Gorbach S.L., and Goldin B.R. Treatment of relapsing Clostridium difficile diarrhea with Lactobacillus GG. Nutrition Today 31 (1996) 35S-38S
5. Lee Y.K., Puong K.Y., Ouwehand A.C., and Salminen S. Displacement of bacterial pathogens from mucus and Caco-2 cell surface by Lactobacilli. J. Med. Microbiol. 52 (2003) 925-930
6. Hartley M.G., Hudson M.J., Swarbrick E.T., Hill M.J., Gent A.E., Hellier M.D., and Grace R.H. The rectal mucosa-associated microflora in patients with ulcerative colitis. J. Med. Microbiol. 36 (1992) 96-103
7. Favier C., Neut C., Mizon C., Cortot A., Colombel J.F., and Mizon J. Fecal beta-d-galactosidase production and Bifidobacteria are decreased in Crohn's disease. Dig. Dis. Sci. 42 (1997) 817-822
8. Hove H., Norgaard H., and Mortensen P.B. Lactic acid bacteria and the human gastrointestinal tract. Eur. J. Clin. Nutr. 53 (1999) 339-350
9. Aso Y., Akaza H., Kotake T., Tsukamoto T., Imai K., and Naito S. Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. Eur. Urol. 27 (1995) 104-109
10. Anderson J.W., and Gilliland S.E. Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J. Am. Coll. Nutr. 18 (1999) 43-50
11. Calinescu C., Mulhbacher J., Nadeau E., Fairbrother J.M., and Mateescu M.A. Carboxymethyl high amylose starch (CM-HAS) as excipient for Escherichia coli oral formulations. Eur. J. Pharm. Biopharm. 60 (2005) 53-60
12. Calinescu C., Nadeau E., Mulhbacher J., Fairbrother J.M., and Mateescu M.A. Carboxymethyl high amylose starch for F4 fimbriae gastro-resistant oral formulation. Int. J. Pharm. 343 (2007) 18-25
13. M. Leonida, M.A. Mateescu, Drug release profiles from Chitosan - carboxymethyl-starch matrices stabilized by ionic interactions. Transactions of the 33rd Annual Meeting and Exposition of the Controlled Release Society, 2006, #827.
14. Chang K.L.B., Tsai G., Lee J., and Fu W.R. Heterogeneous N-deacetylation of chitin in alkaline solution. Carbohydr. Res. 303 (1997) 327-332
15. Araki Y., and Ito E. Chitin deacetylase. Methods Enzymol. 161 (1988) 510-514
16. Tozaki H., Komoike J., Tada C., Maruyama T., Terabe A., Suzuki T., Yamamoto A., and Muranishi S. Chitosan capsules for colon-specific drug delivery: improvement of insulin absorption from the rat colon. J. Pharm. Sci. 86 (1997) 1016-1021
17. Miyazaki S., Nakayama A., Oda M., Takada M., and Attwood D. Drug release from oral mucosal adhesive tablets of chitosan and sodium alginate. Int. J. Pharm. 118 (1995) 257-263
18. Chellat F., Tabrizian M., Dumitriu S., Chornet E., Magny P., Rivard C.H., and Yahia L. In vitro and in vivo biocompatibility of chitosan-xanthan polyionic complex. J. Biomed. Mater. Res. 51 (2000) 107-116
19. Rinaudo M., Milas M., and Dung P.L. Characterization of chitosan. Influence of ionic strength and degree of acetylation on chain expansion. Int. J. Biol. Macromol. 15 (1993) 281-285
20. Wang W., Bo S., Li S., and Qin W. Determination of the Mark-Houwink equation for chitosans with different degrees of deacetylation. Int. J. Biol. Macromol. 13 (1991) 281-285
21. U. S. Pharmacopeia National Formulary U.S.P. XXIV, NF XIX, United States Pharmacopeial Convention Inc., Rockville, MD, 2000.
22. No H.K., Park N.Y., Lee S.H., and Meyers S.P. Antibacterial activity of chitosans and chitosan oligomers with different molecular weights. Int. J. Food Microbiol. 74 (2002) 65-72
23. Young D.H., Kohle H., and Kauss H. Effect of chitosan on membrane permeability of suspension-cultured glycine max and Phaseolus vulgaris cells. Plant Physiol. 70 (1982) 1449-1454
24. Kristl J., Smid-Korbar J., Struc E., Schara M., and Rupprecht H. Hydrocolloids and gels of chitosan as drug carriers. Int. J. Pharm. 99 (1993) 13-19
25. Sakkinen M., Seppala U., Heinanen P., and Marvola M. In vitro evaluation of microcrystalline chitosan (MCCh) as gel-forming excipient in matrix granules. Eur. J. Pharm. Biopharm. 54 (2002) 33-40
26. Sabnis S., Rege P., and Block L.H. Use of chitosan in compressed tablets of diclofenac sodium: inhibition of drug release in an acidic environment. Pharm. Dev. Technol. 2 (1997) 243-255
27. Zhang H., and Neau S.H. In vitro degradation of chitosan by bacterial enzymes from rat cecal and colonic contents. Biomaterials 23 (2002) 2761-2766
28. Pye G., Evans D.F., Ledingham S., and Hardcastle J.D. Gastrointestinal intraluminal pH in normal subjects and those with colorectal adenoma or carcinoma. Gut 31 (1990) 1355-1357